Literature DB >> 33363009

Systemic Inflammation Response Index Is a Predictor of Poor Survival in Locally Advanced Nasopharyngeal Carcinoma: A Propensity Score Matching Study.

Yuhua Feng1, Na Zhang1, Sisi Wang1, Wen Zou1, Yan He1, Jin-An Ma1, Ping Liu1, Xianling Liu1, Chunhong Hu1, Tao Hou1.   

Abstract

INTRODUCTION: Nasopharyngeal carcinoma (NPC) is a common malignancy in China and known prognostic factors are limited. In this study, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune inflammation index (SII), and systemic inflammation response index (SIRI) were evaluated as prognostic factors in locally advanced NPC patients.
MATERIALS AND METHODS: NPC patients who received curative radiation or chemoradiation between January 2012 and December 2015 at the Second Xiangya Hospital were retrospectively reviewed, and a total of 516 patients were shortlisted. After propensity score matching (PSM), 417 patients were eventually enrolled. Laboratory and clinical data were collected from the patients' records. Receiver operating characteristic curve analysis was used to determine the optimal cut-off value. Survival curves were analyzed using the Kaplan-Meier method. The Cox proportional hazard model was used to identify prognostic variables.
RESULTS: After PSM, all basic characteristics between patients in the high SIRI group and low SIRI group were balanced except for sex (p=0.001) and clinical stage (p=0.036). Univariate analysis showed that NLR (p=0.001), PLR (p=0.008), SII (p=0.001), and SIRI (p<0.001) were prognostic factors for progression-free survival (PFS) and overall survival (OS). However, further multivariate Cox regression analysis showed that only SIRI was an independent predictor of PFS and OS (hazard ratio (HR):2.83; 95% confidence interval (CI): 1.561-5.131; p=0.001, HR: 5.19; 95% CI: 2.588-10.406; p<0.001), respectively.
CONCLUSION: Our findings indicate that SIRI might be a promising predictive indicator of locally advanced NPC patients.
Copyright © 2020 Feng, Zhang, Wang, Zou, He, Ma, Liu, Liu, Hu and Hou.

Entities:  

Keywords:  locally advanced; nasopharyngeal carcinoma; prognosis; survival; systemic inflammation response index

Year:  2020        PMID: 33363009      PMCID: PMC7759154          DOI: 10.3389/fonc.2020.575417

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  34 in total

1.  A novel systemic inflammation response index (SIRI) for predicting postoperative survival of patients with esophageal squamous cell carcinoma.

Authors:  Yiting Geng; Danxia Zhu; Chen Wu; Jun Wu; Qi Wang; Ruiqi Li; Jingting Jiang; Changping Wu
Journal:  Int Immunopharmacol       Date:  2018-11-05       Impact factor: 4.932

2.  Platelet-Lymphocyte Ratio as a Predictor of Prognosis in Head and Neck Cancer: A Systematic Review and Meta-Analysis.

Authors:  Yonatan Bardash; Caitlin Olson; Wendy Herman; Julian Khaymovich; Peter Costantino; Tristan Tham
Journal:  Oncol Res Treat       Date:  2019-09-24       Impact factor: 2.825

Review 3.  Inflammasomes and Cancer.

Authors:  Rajendra Karki; Si Ming Man; Thirumala-Devi Kanneganti
Journal:  Cancer Immunol Res       Date:  2017-01-16       Impact factor: 11.151

4.  Induction versus adjuvant chemotherapy combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A propensity score-matched analysis.

Authors:  Si-Qi Tang; Cheng Xu; Xiao-Shuai Wang; Ling-Long Tang; Wen-Fei Li; Lei Chen; Yan-Ping Mao; Rui Guo; Qing Liu; Ying Sun; Jun Ma
Journal:  Oral Oncol       Date:  2020-04-11       Impact factor: 5.337

Review 5.  Tumor-associated macrophages: role in cancer development and therapeutic implications.

Authors:  Arash Salmaninejad; Saeed Farajzadeh Valilou; Arash Soltani; Sepideh Ahmadi; Yousef Jafari Abarghan; Rhonda J Rosengren; Amirhossein Sahebkar
Journal:  Cell Oncol (Dordr)       Date:  2019-05-29       Impact factor: 6.730

6.  Prognostic capacity of Systemic Inflammation Response Index (SIRI) in patients with head and neck squamous cell carcinoma.

Authors:  Cristina Valero; Laura Pardo; Aina Sansa; Jacinto Garcia Lorenzo; Montserrat López; Miquel Quer; Xavier León
Journal:  Head Neck       Date:  2019-11-21       Impact factor: 3.147

7.  Albumin-to-Alkaline Phosphatase Ratio: A Novel Prognostic Index of Overall Survival in Cisplatin-based Chemotherapy-treated Patients with Metastatic Nasopharyngeal Carcinoma.

Authors:  Man Nie; Peng Sun; Cui Chen; Xiwen Bi; Yu Wang; Hang Yang; Panpan Liu; Zhiming Li; Yi Xia; Wenqi Jiang
Journal:  J Cancer       Date:  2017-02-25       Impact factor: 4.207

8.  A Novel Prognostic Marker Systemic Inflammation Response Index (SIRI) for Operable Cervical Cancer Patients.

Authors:  Bei Chao; Xiaoli Ju; Lirong Zhang; Xin Xu; Yan Zhao
Journal:  Front Oncol       Date:  2020-05-13       Impact factor: 6.244

9.  Neutrophil-to-lymphocyte ratio and platelet count as prognostic factors in ovarian malignancies.

Authors:  Rosekeila Simões Nomelini; Ana Flávia Carrijo Chiovato; Fernanda Beatriz Ferreira Abdulmassih; Rafael de Carvalho da Silva; Beatriz Martins Tavares-Murta; Eddie Fernando Candido Murta
Journal:  J Cancer Res Ther       Date:  2019 Oct-Dec       Impact factor: 1.805

10.  Prognostic value of systemic inflammatory factors NLR, LMR, PLR and LDH in penile cancer.

Authors:  Chen Hu; Yu Bai; Jun Li; Guoyin Zhang; Libo Yang; Chengwei Bi; Bin Zhao; Yong Yang; Ruiqian Li; Hongyi Wu; Qilin Wang; Yang Qin
Journal:  BMC Urol       Date:  2020-05-27       Impact factor: 2.264

View more
  7 in total

1.  Systemic Immun e-Inflammation Index as a Predictor for Head and Neck Cancer Prognosis: A Meta-Analysis.

Authors:  Yun-Ting Wang; Liang-Tseng Kuo; Hsu-Huei Weng; Cheng-Ming Hsu; Ming-Shao Tsai; Geng-He Chang; Yi-Chan Lee; Ethan I Huang; Yao-Te Tsai
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

2.  A Risk Model Composed of Complete Blood Count, BRAF V600E and MAP2K1 Predicts Inferior Prognosis of Langerhans Cell Histiocytosis in Children.

Authors:  Leyuan Wang; Lin Yuan; Xizi Du; Kai Zhou; Yu Yang; Qingwu Qin; Liangchun Yang; Yang Xiang; Xiangping Qu; Huijun Liu; Xiaoqun Qin; Chi Liu
Journal:  Front Oncol       Date:  2022-02-04       Impact factor: 6.244

3.  Prognostic Value of Inflammatory Markers in Nasopharyngeal Carcinoma Patients in the Intensity-Modulated Radiotherapy Era.

Authors:  Qian Li; Lushi Yu; Pengcheng Yang; Qinyong Hu
Journal:  Cancer Manag Res       Date:  2021-08-31       Impact factor: 3.989

4.  Systemic Inflammation Response Index as a Prognostic Marker in Cancer Patients: A Systematic Review and Meta-Analysis of 38 Cohorts.

Authors:  Qian Zhou; Si Su; Wen You; Tao Wang; Tong Ren; Lan Zhu
Journal:  Dose Response       Date:  2021-12-15       Impact factor: 2.658

5.  Preoperative systemic inflammatory response index predicts long-term outcomes in type B aortic dissection after endovascular repair.

Authors:  Yufei Zhao; Xiang Hong; Xinsheng Xie; Daqiao Guo; Bin Chen; Weiguo Fu; Lixin Wang
Journal:  Front Immunol       Date:  2022-09-28       Impact factor: 8.786

6.  Radiomics Metrics Combined with Clinical Data in the Surgical Management of Early-Stage (cT1-T2 N0) Tongue Squamous Cell Carcinomas: A Preliminary Study.

Authors:  Umberto Committeri; Roberta Fusco; Elio Di Bernardo; Vincenzo Abbate; Giovanni Salzano; Fabio Maglitto; Giovanni Dell'Aversana Orabona; Pasquale Piombino; Paola Bonavolontà; Antonio Arena; Francesco Perri; Maria Grazia Maglione; Sergio Venanzio Setola; Vincenza Granata; Giorgio Iaconetta; Franco Ionna; Antonella Petrillo; Luigi Califano
Journal:  Biology (Basel)       Date:  2022-03-18

7.  Systemic Inflammation Response Index is a Prognostic Risk Factor in Patients with Hepatocellular Carcinoma Undergoing TACE.

Authors:  Jun-Xiang Li; Peng-Fei Pang; Tian-Cheng Wang; Tian-Zhi An
Journal:  Risk Manag Healthc Policy       Date:  2021-06-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.